Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) — Stock Score Summary

Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) has a MoatMap StockRank of 51/100 based on Quality (62/100), Value (43/100), and Momentum (33/100) factor scores. The current signal is HOLD. Shanghai Haohai Biological is a high-margin medical aesthetics player, but it lacks direct alignment with our core macro themes and faces intensifying domestic competition.

Shanghai Haohai Biological Technology Co., Ltd. specializes in the research, development, and manufacture of biomedical materials, focusing on ophthalmology, medical aesthetics, wound care, and orthopedics. The company holds a dominant market position in China's intraocular lens (IOL) and ophthalmic viscoelastic agent markets, supported by strategic acquisitions along the global supply chain. It is a highly profitable, vertically integrated healthcare leader benefiting from China's aging population and growing aesthetic demand.

Key Financial Metrics

Price$4.67
Market Cap$1.1B
P/E (TTM)30.41
P/E (Forward)13.24
Price/Book1.39
Return on Equity3.4%
Return on Invested Capital4.4%
Debt/Equity7.45
Gross Margin68.3%
Operating Margin13.1%
Revenue Growth-7.6%
Dividend Yield3.1%
Free Cash Flow$2M

Shanghai Haohai Biological Technology Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanghai Haohai Biological Technology Co., Ltd.’s (688366.SS) StockRank?
MoatMap’s StockRank for Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) is 51/100, with a Hold signal. It is a composite of Quality (62), Value (43), and Momentum (33) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shanghai Haohai Biological Technology Co., Ltd. have an economic moat?
Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) has a Quality factor score of 62/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanghai Haohai Biological Technology Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) is Hold, based on a StockRank of 51/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanghai Haohai Biological Technology Co., Ltd. in?
Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).